Susan Mary Shanley

Title: Susan Mary Shanley: Innovator in Tumor Suppressor Research

Introduction

Susan Mary Shanley is a prominent inventor based in Norman Park, Australia. She has made significant contributions to the field of cancer research, particularly in the area of basal cell carcinoma. With a total of 2 patents, her work has the potential to impact the understanding and treatment of this type of skin cancer.

Latest Patents

Shanley's latest patents focus on tumor suppressor genes that play a crucial role in nevoid basal cell carcinoma syndrome. The first patent, titled "Basal cell carcinoma tumor suppressor protein," provides insights into the inactivation of a tumor suppressor gene, which is a causal factor in this syndrome and various sporadic basal cell carcinomas. The NBCCS gene, which she studies, is a homologue of the patched (ptc) gene. Her second patent, "Basal cell carcinoma tumor suppressor gene," reiterates the importance of this gene in the context of tumor suppression and its implications for cancer research.

Career Highlights

Susan Mary Shanley is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to collaborate with leading experts in the field, further enhancing her research capabilities and contributions.

Collaborations

Some of her notable coworkers include Michael C. Dean and Heidi Eve Hahn. Their collaborative efforts have likely enriched the research environment and fostered innovative approaches to cancer treatment.

Conclusion

Susan Mary Shanley is a dedicated inventor whose work in tumor suppressor research is paving the way for advancements in understanding and treating basal cell carcinoma. Her contributions are invaluable to the scientific community and hold promise for future breakthroughs in cancer therapy.